Skip to main content
. 2008 Feb 19;98(6):1141–1146. doi: 10.1038/sj.bjc.6604260

Table 2. Clinical variables statistically associated with Gas6.

    Gas6 mRNA
 
Variable   <2.2 × 106 >2.2 × 106 P-value
PRB IHC (n=30)
 Negative (⩽10%)   10 (77%) 3 (23%) 0.04
 Positive (>10%)   7 (35%) 11 (65%)  
         
    <Mean >Mean  
Lymph node metastases (n=49)
 Average (s.d.)   4.219 (5.35) 0.5 (1.07) 0.0002
 (s.e.m.)   (0.84) (0.378)  
         
    <Mean >Median  
Nuclear morphology (NM) (n=38)
 NM=1 or 2 (n=7)   4 (57%) 3 (43%) 0.03
 NM=3 (n=31)   28 (90.3%) 3 (9.7%)  
    <Median >Median  
Age (n=49)        
 ⩽50 years (n=24)   2 (20%) 8 (80%) 0.04
 >50 years (n=25)   22 (56%) 17 (44%)  
         
Margin type (n=38)
 Infiltrating (n=19)   13 (65%) 7 (35%) 0.05
 Pushing (n=19)   6 (33%) 12 (67%)  
         
  0 <Mean >Mean  
Size (n=49)
 Continuous variable        
 Mean (s.d.) 54.83 (29.87) 37.19 (18.9) 22.33 (5.8) 0.02
         
NPI (n=49)
 Continuous variable        
 Mean (s.d.) 5.76 (1.35) 5.12 (1.18) 3.94 (0.59) 0.03

IHC=immunohisto chemistry; NPI=Nottingham prognostic index; PRB=progesterone B.